Clinical Trials

In order to win regulatory approval, new drugs must pass through the three phases of clinical trials. To continually improve this years-long and arduous process that involves complex regulations, companies can leverage digital platforms and technologies and new strategies for trial design to make it to the finish line.

Articles

PM2206-HERO-575x327-Development
PM2206-HERO-575x327-Development
PM2206-HERO-575x327-Development
PM2206-HERO-575x327-Development
PM2206-HERO-575x327-Development

10 tips for improved drug development

Comprehensive strategies to save time and reduce cost in end-to-end clinical development
PM2203-HERO-880x500-CoverStory
PM2203-HERO-880x500-CoverStory
PM2203-HERO-880x500-CoverStory
PM2203-HERO-880x500-CoverStory
PM2203-HERO-880x500-CoverStory

HIV: An ending in the balance

Incorporating cures into pharma's HIV epidemic equation
PM2202-HERO-575x327-Quality-copy2
PM2202-HERO-575x327-Quality-copy2
PM2202-HERO-575x327-Quality-copy2
PM2202-HERO-575x327-Quality-copy2
PM2202-HERO-575x327-Quality-copy2

Juggling the regulatory complexities of global clinical trials

Deploying an automated process can help simplify safety and compliance information
shutterstock-1263998260
shutterstock-1263998260
shutterstock-1263998260
shutterstock-1263998260
shutterstock-1263998260

Taking mental health above ground

It’s imperative that pharma stays on board with solutions
PM2112-HERO-575x327-CoverStory
PM2112-HERO-575x327-CoverStory
PM2112-HERO-575x327-CoverStory
PM2112-HERO-575x327-CoverStory
PM2112-HERO-575x327-CoverStory

Minding the gap

As holes in mental health treatment deepen, can pharma fill the voids?
global-nov
global-nov
global-nov
global-nov
global-nov

Global Dose: Focus on Lithuania

A small country looking to make big moves in pharma
PM2111-HERO-575x327-Operations
PM2111-HERO-575x327-Operations
PM2111-HERO-575x327-Operations
PM2111-HERO-575x327-Operations
PM2111-HERO-575x327-Operations

Leave no CMC stone unturned

Building a CMC strategy for biologics is a critical, multistep process
PM2111-HERO-575x327-CoverStory
PM2111-HERO-575x327-CoverStory
PM2111-HERO-575x327-CoverStory
PM2111-HERO-575x327-CoverStory
PM2111-HERO-575x327-CoverStory

2021 Pharma Innovation Awards

Unveiling this year's winners
PM2109-HERO-575x327-Automation
PM2109-HERO-575x327-Automation
PM2109-HERO-575x327-Automation
PM2109-HERO-575x327-Automation
PM2109-HERO-575x327-Automation

Mastering the sample management ecosystem

A holistic, flexible approach to managing critical research assets can be a drug development game-changer
shutterstock-1120206911
shutterstock-1120206911
shutterstock-1120206911
shutterstock-1120206911
shutterstock-1120206911

The fittest model

Is it time for pharma to evolve its drug development ways?
PM20XX-HERO-575x327-CoverStory
PM20XX-HERO-575x327-CoverStory
PM20XX-HERO-575x327-CoverStory
PM20XX-HERO-575x327-CoverStory
PM20XX-HERO-575x327-CoverStory

The next phase of drug creation

Why animal models are on the brink of extinction
PM2104-HERO-575x327-Pipeline
PM2104-HERO-575x327-Pipeline
PM2104-HERO-575x327-Pipeline
PM2104-HERO-575x327-Pipeline
PM2104-HERO-575x327-Pipeline

Pipeline snapshot: Two treatments that could change the game for Alzheimer’s

It’s no secret that the pipeline for Alzheimer’s treatments has mostly become a sinkhole for dozens of failed drugs and billions in lost R&D dollars. But with the stakes so high...
PM2203-HERO-880x500-CoverStory
PM2203-HERO-880x500-CoverStory
PM2203-HERO-880x500-CoverStory
PM2203-HERO-880x500-CoverStory
PM2203-HERO-880x500-CoverStory

The Alzheimer's approval maze

Navigating one of the FDA's biggest decisions of the decade
PM2101-Predictions-Logo
PM2101-Predictions-Logo
PM2101-Predictions-Logo
PM2101-Predictions-Logo
PM2101-Predictions-Logo

Top pharma industry predictions for 2021

In many ways, the beginning of 2021 isn’t just one of the most welcome New Years of the modern era — it could also be a turning point between the pre-COVID and post-COVID worlds...
enterprise
enterprise
enterprise
enterprise
enterprise

Pharma's warp drive

The key factors helping drugmakers develop a vaccine in record time